Baldwin Wealth Partners’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-3,595
Closed -$360K 673
2024
Q3
$360K Buy
+3,595
New +$360K 0.02% 246